About Invizius
Invizius is a company based in Edinburgh (United Kingdom) founded in 2018. Invizius has raised $13.09 million across 6 funding rounds from investors including Mercia, Downing and Scottish Enterprise. The company has 12 employees. Invizius offers products and services including H-Guard and PspCN. Invizius operates in a competitive market with competitors including VenoStent, Renal Solutions, Redsense Medical, Health Line International Corporation and Peace and Quiet Care, among others.
- Headquarter Edinburgh, United Kingdom
- Employees 12
- SectorsHealthcare
- Website invizius.com
- Social LinkedIn X
- Legal Name Invizius Limited
- Date of Incorporation 26 Jan, 2018
- Jurisdiction EDINBURGH, UNITED KINGDOM
- Total Equity Funding$13.09M (USD)
in 6 rounds
- Latest Funding Round$1.27M (USD), Series A
Sep 2024
- InvestorsMercia
& 9 more
- Employee Count12
Products & Services of Invizius
Invizius offers a comprehensive portfolio of products and services, including H-Guard and PspCN.
Complement therapy for patients on dialysis and extracorporeal circuits.
Technology to supercharge natural regulators for enhanced efficacy.
Funding Insights of Invizius
Invizius has successfully raised a total of $13.09M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $1.27 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $13.09M
- Total Rounds 6
- Last Round Series A — $1.27M
- First Round $683,896
(May 2018)
- Investors Count 10
All 6 funding rounds of Invizius with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
10 investors in total: 9 institutional and 1 angel.
Investors in Invizius
Invizius has secured backing from 10 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Mercia, Downing and Scottish Enterprise.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
UK venture capital investments are managed by Calculus Capital. | 1999 | calculuscapital.com | London, United Kingdom | |
- | – | oldcollegecapital.co.uk | - | |
Inheritance tax relief, funds, and bonds are provided across sectors. | 1986 | downing.co.uk | London, United Kingdom | |
Accelerator firm backed by Solvay | – | solvay.com/en/innovation/solvay-ventures/start-up-pitch-brussels-hq | Brussels, Belgium | |
Investment management services are provided by Mercia to various clients. | 1982 | mercia.co.uk | - | |
Solutions for materials and chemicals are provided across industries. | 2023 | syensqo.com | Brussels, Belgium | |
Business development and leadership training programs are offered to companies. | 1991 | scottish-enterprise.com | Glasgow, United Kingdom | |
Inorganic chemicals and advanced materials are manufactured for various industries. | 1863 | solvay.com | Brussels, Belgium | |
- | – | scottish-enterprise.com/sib | - | |
JM Jonathan Milner | British angel investor, founder of Abcam, active in biotech and life sciences. | – | unknown_999498efe7254797b | - |
Investor details for Invizius
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Invizius
1 people are tracked at Invizius (1 in leadership); the tracked headcount is 12.
| Name | Role | Group |
|---|---|---|
Richard Boyd | CEO | Leadership |
Complete people profiles for Invizius
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Invizius
3 dated milestones of Invizius across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Invizius is founded.
- Funding First funding round of $684K.
- Funding Latest funding round, Series A, of $1.3M.
Competitors of Invizius
Invizius operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as VenoStent, Renal Solutions, Redsense Medical, Health Line International Corporation and Peace and Quiet Care, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| venostent.com | 2017 | Nashville, United States | $23.36M | – | Shape memory polymer stents are developed for vascular surgery applications. | |
| renalsolutionsinc.com | 2000 | Warrendale, United States | $34.5M | – | Sorbents for renal replacement therapy are developed using regenerative technology. | |
| redsensemedical.com | 2006 | Halmstad, Sweden | – | – | Blood access is monitored during hemodialysis via alarm systems. | |
| hlic.net | 2004 | Salt Lake, United States | – | – | Contract Manufacturer of Dialysis products, Also sells own product lines. | |
| peaceandquietcare.co.uk | 2017 | Manchester, United Kingdom | – | – | Develops innovative renal dialysis machines with soundproof boxes. | |
| dotomedical.com | 2023 | Wrocaw, Poland | – | – | Develops medical devices to enhance hemodialysis and treat kidney disease. | |
| medcomp.net | 1978 | – | – | – | - | |
| oasproject.com | 2016 | Madrid, Spain | – | – | Develops accessory devices to support dialysis treatments. | |
| oxyless.com | 2010 | London, United Kingdom | – | – | Develops bloodlines for dialysis treatments to enhance patient care. |
Detailed competitors of Invizius
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Invizius
Complete news archive for Invizius
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Invizius
10 companies that operate in the same segment as Invizius (Nephrology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Implantable battery-powered pumps for ascites removal are developed. | 2006 | Zurich, Switzerland | USD 35.5 M | – | – | |
Hemodialysis machines with touchscreen displays are provided for medical use. | 2003 | San Jose, California, United States | USD 467.37 M | USD 119.48 M | – | |
Haemodialysis systems are developed for home and clinic applications. | 2008 | Alcester, Warwickshire, United Kingdom | USD 432.84 M | USD 1.4 M | 100 | |
Provider of small molecule based drug for inflammatory kidney disease | 2004 | Stockholm, Sweden | USD 44.83 M | – | 40 | |
Therapeutics are developed for diseases with impaired kidney function. | 2014 | Lyon, Auvergne-rhone-alpes, France | USD 120.34 M | – | – | |
Therapeutics for kidney disease treatment are developed by Akebia Therapeutics. | 2007 | Cincinnati, Ohio, United States | USD 91 M | USD 236.2 M | 181 | |
Biotherapeutics for life-threatening diseases are developed, produced, and commercialized. | 2006 | Pune, Maharashtra, India | – | USD 45.26 M | 705 | |
Biomarker-based diagnostic solutions for cancer and cardiovascular diseases are developed. | 2002 | Hennigsdorf, Brandenburg, Germany | USD 36.14 M | – | – | |
Therapeutics for various kidney diseases are developed. | 2018 | Shanghai, China | USD 114.5 M | – | – | |
Developer of portable hemodialysis device | 2013 | Irvine, California, United States | USD 82.5 M | – | 40 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Invizius
Invizius was founded in 2018.
Invizius is headquartered in Edinburgh, United Kingdom. It is registered at Edinburgh, Scotland, United Kingdom.
Richard Boyd is the current CEO of Invizius.
Invizius is a funded company, having raised a total of $13.09M across 6 funding rounds to date. The company's 1st funding round was a Seed of $683.9K, raised on May 2018.
Invizius has 12 employees.
Invizius was founded in 2018 in Edinburgh, United Kingdom, within the medical devices sector focused on dialysis technology. Priming solutions for hemodialyzers are developed by the company, with H-Guard as the primary product under development. This solution incorporates a hemocompatible coating to mitigate foreign body reactions in blood during dialysis procedures. Applications target hollow fibers in dialyzers, where membrane inflammation in patients blood is addressed through reduced interactions.
Invizius's top competitors include VenoStent, Redsense Medical and Renal Solutions.
Invizius offers H-Guard and PspCN.
Invizius has 10 investors. Key investors include Mercia, Downing, Scottish Enterprise, Calculus Capital, and Solvay.
Invizius operates through Invizius Limited.